Background Recent publications describe recommended ranges for post-operative radiographic measurements, such as the lateralization shoulder angle (LSA) and distalization shoulder angle (DSA), to optimize patient outcomes. However, no consensus exists on optimal implant positioning for reverse total shoulder arthroplasty (rTSA). The purpose of this study was to identify pre- and post-operative radiographic measurements in patients who achieved excellent range of motion to optimize implant positioning in patients undergoing rTSA. We hypothesized that restoring the lateral humeral offset to closely align with the patient’s pre-operative anatomy, along with achieving optimal lateralization and distalization shoulder angles as outlined in the literature, would correlate with excellent clinical outcomes. Methods A total of 425 patients with end-stage glenohumeral arthritis or irreparable rotator cuff arthropathy underwent rTSA from January 2021 to January 2023 at an outpatient orthopedic surgery center. Of these patients, 33 were identified as achieving excellent range of motion 6 months post-operatively, defined as exceeding active forward flexion ≥ 170º and active external rotation > 60º. Exclusions included prior shoulder surgery (n=2), revision from anatomic total shoulder arthroplasty to rTSA (n=2), pre-operative fracture (n=1), and bilateral procedures (n=1), leaving 27 patients. Both medialized (Zimmer TM rTSA) and lateralized (Tornier Perform) devices were used during the study. Radiographic measurements of the patients’ pre- and post-operative shoulder anatomy were recorded from two independent reviewers. Measurements were reported as the mean ± standard deviation and the inter-observer correlation assessed using the intra-class correlation coefficient. Results Patients were 51.9% female, with a mean age of 68.2 years at operation. 13 patients received the medialized inlay and 14 received the lateralized inlay rTSA. The average post-operative lateralization shoulder angle (LSA) and distalization shoulder angle (DSA) were 90º and 43º, respectively. The acromiohumeral interval (AHI) distalized an average of 22 mm, from a mean pre-operative length of 7 mm to a mean post-operative length of 29 mm (p < .001). The post-operative lateral humeral offset (LHO) on average was within 3.1 ± 4.4 mm of the patients’ pre-operative anatomy (p < .001). The medialized inlay did not significantly differ from the lateralized inlay in any radiographic measurements except in LHO. The post-operative LHO of the medialized inlay was 55 mm and the lateralized inlay was 66 mm (p < .001). Conclusion In patients who achieved excellent range of motion following rTSA, the lateral humeral offset was restored very closely to pre-operative anatomy, the lateralization and distalization shoulder angles were also restored within optimal ranges defined in the literature, and the acromiohumeral interval was distalized by an average of 22 mm. This study demonstrates that post-operative restoration of lateral humeral offset to pre-operative measurements is correlated with excellent post-operative outcomes. Level of Evidence: Treatment Study – Level IV
Objective: To evaluate the clinical outcomes of cochlear implantation (CI) in 3 familial patients with Alport syndrome. Patients: Three familial patients—a father and 2 daughters—diagnosed with Alport syndrome who underwent CI due to progressive sensorineural hearing loss. Intervention: CI was performed between 1999 and 2024 at a tertiary academic medical center. Patient 1 received a left Cochlear Americas CI 24 Nucleus, patient 2 a right Cochlear Nucleus CI24RE with Contour Advance, and patient 3 a right Cochlear Americas CI 622. Main outcome measures: Preoperative and postoperative consonant-nucleus-consonant (CNC) and Arizona Bioindustry Association (AzBio) scores, as well as pure-tone average (PTA). Results: Postoperative PTA was 30 dB for patient 1, 25 dB for patient 2, and 30 dB for patient 3. Patient 1 had limited pre-implantation records, but 16 years post-implantation, he had a CNC of 64% and AzBio of 47%. Patient 2’s right-sided preoperative CNC and AzBio were both 0% with a PTA of 110 dB. At 10 years postop, her CNC improved to 92% and AzBio to 87%. Patient 3’s preoperative CNC was 56% in each ear and her AzBio was 60% in the bilateral condition with a PTA of 96 dB. At 3 months post-CI, her CNC improved to 84% and AzBio was 62% for the CI ear only. Conclusions: This novel case series highlights successful unilateral CI in Alport syndrome-related hearing loss without complications. These findings support further research on CI efficacy in individuals with Alport syndrome and other collagen-related disorders.
Purpose: Gabapentinoids are increasingly incorporated into multimodal analgesia after orthopaedic surgery, yet their impact on outcomes following fracture fixation remains unclear. This study evaluated the association between early postoperative gabapentinoid–opioid co-prescription and clinical outcomes after operative fixation of closed long bone fractures.Methods: Using the TriNetX Research Network, we identified opioid-naïve and gabapentinoid-naïve adults undergoing intramedullary or plate-and-screw fixation of isolated closed diaphyseal tibia, humerus, or femur fractures. Patients prescribed both gabapentin or pregabalin and opioids within three days after surgery were compared with patients receiving opioids alone. Propensity score matching (1:1) was used to control for demographics, medical comorbidities, fracture location, fixation method, mental health disorders, and substance use disorders. Primary outcomes were prolonged (30–90 days) and chronic (90–180 days) postoperative opioid use. Secondary outcomes included 30-day emergency department (ED) visits and readmissions, and 1-year nonunion and reoperation.Results: After matching, each cohort consisted of approximately 2,000 patients (range, 1,946-2,012). Gabapentinoid–opioid therapy was associated with higher rates of prolonged (21.0% vs 16.1%; RR 1.31; p<0.001) and chronic (9.8% vs 7.4%; RR 1.33; p=0.007) postoperative opioid use. Patients receiving gabapentinoid–opioid therapy had fewer 30-day ED visits (25.1% vs 42.5%; RR 0.59; p<0.001), while 30-day readmission rates were similar between groups (p=0.174). One-year rates of nonunion (4.3% vs 1.9%; RR 2.21; p<0.001) and reoperation (7.1% vs 4.2%; RR 1.68; p<0.001) were significantly higher among patients receiving gabapentinoid–opioid therapy.Conclusion: Early postoperative gabapentinoid–opioid therapy after long bone fracture fixation was associated with fewer ED visits but substantially higher risks of prolonged and chronic opioid use, nonunion, and the need for reoperation. These findings suggest that potential short-term analgesic benefits may be offset by adverse long-term outcomes, warranting caution and future study in the use of gabapentinoid prescribing to manage acute perioperative fracture pain.
With no clear consensus on absorbable verses non-absorbable suture-usage for glabrous skin closures, the purpose of this study was to investigate whether incisions closed with Monocryl sutures displayed higher wound complication rates than nylon sutures following carpal tunnel and trigger finger release surgery. A total of 155 carpal tunnel or trigger finger release surgeries in 138 patients performed in an outpatient academic medical center were analyzed. Patients with pre-operative trauma or infection, or who received concurrent surgeries were excluded. Incisions were closed using either 4-0 poliglecaprone 25 (Monocryl) or 4-0 nylon (Ethilon). Suture choice was determined via a pseudo-randomized method: Monocryl sutures were utilized in surgeries performed on even dates (e.g. 4/10/2024) and nylon sutures on odd dates (e.g. 4/11/2024). The medical records were reviewed for demographics and wound-related complications occurring within 90 days post-surgery. Criteria including additional medical encounters, co-morbidities, and assisting resident level-of-training between Monocryl and nylon cohorts were also evaluated for differences in complication rates. There were 86 carpal tunnel release (55.5 %) and 69 trigger finger release (44.5 %) surgeries. The average age at surgery was 62.4 ± 11.6 years, with Monocryl used in 73 (47.1 %) and nylon in 82 (52.9 %) procedures. The rates of infection requiring antibiotics were similar between Monocryl (4.1 %, n = 3) and nylon cohorts (2.4 %, n = 2). However, higher rates of dehiscence were observed with Monocryl (11.0 %, n = 8) compared to nylon (2.4 %, n = 2). Multivariable logistic regression showed that inflammatory arthritis, immunosuppressant drug use, and junior resident assistance were independent predictors of wound complications. In conclusion, we found usage of Monocryl sutures following carpal tunnel and trigger finger release associated with higher a dehiscence rate within 90 days post-operation. Additionally, factors including resident training level, immunosuppression, and inflammatory arthritis were associated with increased complications. Therapeutic IV.
To evaluate whether preoperative use of selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs) is associated with increased risk of reoperation, nonunion, infection, hospital readmission, or emergency department (ED) visits following operative fixation of isolated long bone fractures. This retrospective, multicenter cohort study was conducted using the TriNetX Research Network. Adults (≥18 years) who underwent operative fixation of isolated tibial, femoral, or humeral shaft fractures between 2012 and 2024 were included. Patients prescribed an SSRI or SNRI within 180 days prior to fracture and within 12 months after surgery were compared with controls without antidepressant prescriptions before or within 12 months after fracture. Polytrauma, pathologic fractures, and prior surgery at the same site were excluded. Propensity score matching (1:1) was performed for demographics, fracture location, and relevant medical and psychiatric comorbidities. The primary outcome was reoperation within 12 months. Secondary outcomes included nonunion, infection, hospital readmission, and ED visits. Analyses were stratified by fracture type (open vs closed) and location. A total of 5293 SSRI/SNRI users were matched to 5293 controls. In closed fractures, antidepressant use was associated with higher rates of nonunion (5.2% vs 4.0%; RR 1.29, 95% CI 1.06-1.56). Open fractures demonstrated a trend towards greater rates of nonunion (4.8% vs 3.1%) and reoperation (15.2% vs 13.9%); however, this was not significant. 30-day ED visits, 30-day surgical site infection, and 90-day readmissions were comparable between groups. Preoperative SSRI or SNRI use was associated with increased risk of nonunion following operative fixation of closed long bone fractures. Outcomes following open fractures were largely unaffected, likely due to the dominant biological and mechanical risks inherent to open injuries. These findings suggest the need for increased clinical vigilance in patients with closed fractures receiving serotonergic antidepressants and highlight the importance of prospective studies to further clarify causality and guide management strategies.
25 February 2026 in Journal of Orthopaedic Reports